The first stop for professional medicines advice

Unlicensed medicines

18 results

Applied filters
Registration required

Summary of biopharmaceutical stability data reviewed and available extended shelf-life data

4 June 2021The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.
Registration required

Cabazitaxel: Cytotoxic Drug Stability Monograph

12 March 2021Stability information is essential for the safe aseptic preparation of cabazitaxel
Registration required

Vincristine: Cytotoxic Drug Stability Monograph

15 December 2020Stability information is essential for the safe aseptic preparation of vincristine

Unlicensed medicines

All our advice relating to making, purchasing and using unlicensed medicines.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Using Standardised Strengths of Unlicensed Liquid Medicines in Children

10 October 2019A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)

Risk Associated with the Outsourcing of the Aseptic Compounding of Parenteral Nutrition (Yellow Cover)

16 December 2016The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…

Guidance on Managing The Sourcing and Supply of Ready-to-Administer Chemotheraphy Doses for the NHS (Yellow Cover)

5 December 2016This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.